Unichem Laboratories FY26 BRSR: 100% Pharma Turnover, 97.6% Exports

Unichem Laboratories Ltd has released its Business Responsibility and Sustainability Report for FY 2025-26. The report details that 100% of the company's turnover is derived from the manufacture and sale of pharmaceutical products, specifically Allopathic Medicines. A significant portion, 97.6%, of the total turnover comes from exports. The company serves diverse therapeutic areas and markets globally, primarily selling to its wholly-owned subsidiaries. The report also provides employee data, including a breakdown of permanent and non-permanent employees and workers by gender, and details on differently-abled employees. Women representation on the Board of Directors is 16.67%. Turnover rates for permanent employees and workers over the past three fiscal years are also disclosed.